Ensuring Timely Access to Generics Act of 2021

Summary

Official

Ensuring Timely Access to Generics Act of 2021 This bill imposes requirements related to third-party petitions concerning an application for Food and Drug Administration (FDA) approval to market a generic drug or biosimilar. (The current statute refers to these petitions as citizen petitions , which typically involve requests that the FDA take certain actions,...

How would you vote on this bill?

Yes No

Bill Progress

Bill has been introduced and assigned a number

Introduced(3/3/21)

Committee

Passed House

Passed Senate

President

Law